Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Daniel Jonas. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at Daniel Jonas har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:CNMD / CONMED Corporation | Special Counsel & Corp Secy | 13 462 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Daniel Jonas. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Internkjøp CNMD / CONMED Corporation - Analyse av kortsiktig fortjeneste
I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i CNMD / CONMED Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Handelsdato | Ticker | Innsider | Rapporterte aksjer |
Rapportert pris |
Justerte aksjer |
Justert pris |
Kostpris | Dager til maks |
Pris ved maks |
Maks fortjeneste ($) |
Maks fortjeneste (%) |
---|---|---|---|---|---|---|---|
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen. |
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Internhandel CNMD / CONMED Corporation - Analyse av kortsiktig tap
I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i CNMD / CONMED Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.
Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.
Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av Daniel Jonas som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −200 | 13 462 | −1,46 | 127,56 | −25 512 | 1 717 213 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 300 | 13 662 | −23,94 | 126,72 | −544 896 | 1 731 249 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 500 | 17 962 | −23,44 | 125,57 | −690 635 | 2 255 488 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 462 | 74,28 | 97,69 | 976 900 | 2 292 003 | |
2023-05-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
G - Gift | −626 | 13 462 | −4,44 | ||||
2023-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 40 | 14 088 | 0,28 | 98,67 | 3 947 | 1 390 063 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 14 048 | −26,25 | 96,08 | −480 381 | 1 349 678 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 19 048 | 35,59 | 78,76 | 393 800 | 1 500 220 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 400 | 14 048 | −27,77 | 96,24 | −519 723 | 1 352 050 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 400 | 19 448 | 38,44 | 59,96 | 323 784 | 1 166 102 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | −736 | 14 048 | −4,98 | 96,16 | −70 774 | 1 350 856 | |
2023-03-03 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 2 500 | 14 784 | 20,35 | ||||
2023-01-10 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 24 | 12 284 | 0,20 | 84,21 | 2 021 | 1 034 436 | |
2022-10-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 26 | 12 260 | 0,21 | 76,16 | 1 980 | 933 722 | |
2022-07-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 22 | 12 234 | 0,18 | 90,97 | 2 001 | 1 112 927 | |
2022-04-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 45 | 12 212 | 0,37 | 141,12 | 6 350 | 1 723 357 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −11 157 | 10 000 | −52,73 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 600 | 5 400 | −50,91 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 610 | 0 | −100,00 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −1 390 | 3 610 | −27,80 | ||||
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −11 157 | 12 167 | −47,83 | 142,50 | −1 589 872 | 1 733 798 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 11 157 | 23 324 | 91,70 | 78,76 | 878 725 | 1 836 998 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 600 | 12 167 | −31,52 | 142,50 | −798 000 | 1 733 798 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 600 | 17 767 | 46,03 | 59,96 | 335 776 | 1 065 309 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 610 | 12 167 | −22,88 | 142,42 | −514 141 | 1 732 841 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 610 | 15 777 | 29,67 | 41,93 | 151 367 | 661 530 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −1 390 | 12 167 | −10,25 | 143,30 | −199 181 | 1 743 482 | |
2022-03-08 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 390 | 13 557 | 11,42 | 41,93 | 58 283 | 568 445 | |
2022-03-03 |
|
4 | CNMD |
CONMED Corp
Rsus (restricted Stock Units) |
A - Award | 2 500 | 2 500 | |||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 755 | 20 000 | −15,81 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −1 245 | 23 755 | −4,98 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −3 343 | 21 157 | −13,64 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −500 | 24 500 | −2,00 | ||||
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 755 | 12 167 | −23,58 | 149,46 | −561 206 | 1 818 428 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 755 | 15 922 | 30,86 | 97,69 | 366 826 | 1 555 420 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −1 245 | 12 167 | −9,28 | 150,00 | −186 750 | 1 825 050 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 1 245 | 13 412 | 10,23 | 97,69 | 121 624 | 1 310 218 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 343 | 12 167 | −21,55 | 149,41 | −499 482 | 1 817 886 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 3 343 | 15 510 | 27,48 | 78,76 | 263 295 | 1 221 568 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −500 | 12 167 | −3,95 | 150,03 | −75 015 | 1 825 424 | |
2022-03-01 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 500 | 12 667 | 4,11 | 78,76 | 39 380 | 997 653 | |
2022-02-04 |
|
5 | CNMD |
CONMED Corp
Common Stock |
J - Other | −450 | 450 | −50,00 | ||||
2022-01-05 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 14 | 12 167 | 0,12 | 134,67 | 1 885 | 1 638 530 | |
2021-10-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 16 | 12 153 | 0,13 | 124,29 | 1 989 | 1 510 496 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −11 000 | 11 000 | −50,00 | ||||
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
G - Gift | −1 000 | 12 137 | −7,61 | ||||
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
F - Taxes | −8 327 | 13 137 | −38,80 | 127,56 | −1 062 192 | 1 675 756 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 11 000 | 21 464 | 105,12 | 59,96 | 659 560 | 1 286 981 | |
2021-09-17 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −3 357 | 10 464 | −24,29 | 127,26 | −427 202 | 1 331 618 | |
2021-07-06 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 15 | 13 821 | 0,11 | 130,56 | 1 958 | 1 804 470 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −4 176 | 5 000 | −45,51 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 176 | 13 806 | −23,22 | 145,59 | −607 986 | 2 010 024 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 4 176 | 17 982 | 30,25 | 41,93 | 175 100 | 753 985 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 000 | 22 000 | −18,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −10 000 | 9 176 | −52,15 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −700 | 19 176 | −3,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 13 806 | −26,59 | 142,00 | −710 000 | 1 960 452 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 18 806 | 36,22 | 59,96 | 299 800 | 1 127 608 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −10 000 | 13 806 | −42,01 | 141,08 | −1 410 750 | 1 947 681 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 806 | 72,43 | 41,93 | 419 300 | 998 186 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −100 | 13 806 | −0,72 | 143,30 | −14 330 | 1 978 400 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −600 | 13 906 | −4,14 | 142,58 | −85 549 | 1 982 731 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 700 | 14 506 | 5,07 | 41,93 | 29 351 | 608 237 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −4 176 | 5 000 | −45,51 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −4 176 | 13 806 | −23,22 | 145,59 | −607 986 | 2 010 024 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 4 176 | 17 982 | 30,25 | 41,93 | 175 100 | 753 985 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −5 000 | 22 000 | −18,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −10 000 | 9 176 | −52,15 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Options To Purchase Common Stock |
M - Exercise | −700 | 19 176 | −3,52 | ||||
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −5 000 | 13 806 | −26,59 | 142,00 | −710 000 | 1 960 452 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 5 000 | 18 806 | 36,22 | 59,96 | 299 800 | 1 127 608 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −10 000 | 13 806 | −42,01 | 141,08 | −1 410 750 | 1 947 681 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 10 000 | 23 806 | 72,43 | 41,93 | 419 300 | 998 186 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −100 | 13 806 | −0,72 | 143,30 | −14 330 | 1 978 400 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
S - Sale | −600 | 13 906 | −4,14 | 142,58 | −85 549 | 1 982 731 | |
2021-05-04 |
|
4 | CNMD |
CONMED Corp
Common Stock |
M - Exercise | 700 | 14 506 | 5,07 | 41,93 | 29 351 | 608 237 | |
2021-04-02 |
|
4 | CNMD |
CONMED Corp
Common Stock |
A - Award | 43 | 13 806 | 0,31 | 124,06 | 5 335 | 1 712 772 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −1 000 | 19 876 | −4,79 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 199 | 0 | −100,00 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 150 | 450 | 50,00 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −150 | 13 763 | −1,08 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −150 | 13 763 | −1,08 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −800 | 14 063 | −5,38 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 000 | 14 863 | −6,30 | 121,92 | −121 919 | 1 812 088 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 000 | 15 863 | 6,73 | 41,93 | 41 930 | 665 136 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 199 | 14 863 | −12,89 | 121,84 | −267 934 | 1 810 963 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 199 | 17 062 | 14,80 | 39,87 | 87 674 | 680 262 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 21 250 | 21 250 | |||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 500 | 20 876 | −14,36 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −624 | 24 376 | −2,50 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 221 | 2 199 | −59,43 | ||||
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −2 345 | 14 863 | −13,63 | 123,20 | −288 904 | 1 831 122 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 500 | 17 208 | 25,53 | 41,93 | 146 755 | 721 531 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −624 | 13 708 | −4,35 | 123,28 | −76 924 | 1 689 856 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 624 | 14 332 | 4,55 | 41,93 | 26 164 | 600 941 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 221 | 13 708 | −19,03 | 123,26 | −397 019 | 1 689 643 | |
2021-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 221 | 16 929 | 23,50 | 39,87 | 128 421 | 674 959 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 680 | 5 420 | −33,09 | ||||
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 000 | 8 100 | −19,80 | ||||
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 680 | 13 708 | −16,35 | 101,00 | −270 680 | 1 384 508 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 680 | 16 388 | 19,55 | 39,87 | 106 852 | 653 390 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 13 708 | −12,73 | 100,50 | −201 006 | 1 377 695 | |
2020-11-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 15 708 | 14,59 | 39,87 | 79 740 | 626 278 | |
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −5 000 | 10 100 | −33,11 | ||||
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −5 000 | 13 708 | −26,73 | 96,12 | −480 587 | 1 317 577 | |
2020-11-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 5 000 | 18 708 | 36,48 | 39,87 | 199 350 | 745 888 | |
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 960 | 0 | −100,00 | ||||
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 832 | 13 708 | −21,85 | 94,08 | −360 515 | 1 289 649 | |
2020-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 960 | 17 540 | 39,43 | 51,30 | 254 448 | 899 802 | |
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −600 | 12 580 | −4,55 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 300 | 50,00 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 13 180 | −0,75 | ||||
2020-08-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 349 | 13 280 | −24,67 | 82,66 | −359 488 | 1 097 725 | |
2020-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 224 | 17 629 | 1,29 | 54,41 | 12 188 | 959 194 | |
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 0 | −100,00 | ||||
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −175 | 17 405 | −1,00 | 94,64 | −16 562 | 1 647 209 | |
2020-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 17 580 | 2,03 | ||||
2019-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 15 | 17 230 | 0,09 | 91,34 | 1 370 | 1 573 788 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −1 560 | 0 | −100,00 | ||||
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −12 000 | 15 100 | −44,28 | ||||
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 909 | 17 215 | −14,46 | 92,10 | −267 919 | 1 585 502 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 157 | 20 124 | −5,44 | 92,94 | −107 532 | 1 870 325 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 560 | 21 281 | 7,91 | 44,90 | 70 044 | 955 517 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −8 598 | 19 721 | −30,36 | 92,01 | −791 102 | 1 814 529 | |
2019-08-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 12 000 | 28 319 | 73,53 | 39,87 | 478 440 | 1 129 079 | |
2019-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 55 | 16 319 | 0,34 | 81,29 | 4 471 | 1 326 572 | |
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −1 000 | 16 264 | −5,79 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 264 | −0,58 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 264 | −0,58 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 200 | 100,00 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 0 | −100,00 | ||||
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −325 | 17 464 | −1,83 | 80,48 | −26 156 | 1 405 503 | |
2019-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 17 789 | 3,79 | ||||
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −7 840 | 4 960 | −61,25 | ||||
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 000 | 17 139 | −18,92 | 80,51 | −322 050 | 1 379 902 | |
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −6 358 | 21 139 | −23,12 | 82,48 | −524 408 | 1 743 545 | |
2019-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 7 840 | 27 497 | 39,88 | 51,30 | 402 192 | 1 410 596 | |
2019-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 226 | 19 657 | 1,16 | 79,02 | 17 859 | 1 553 296 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 350 | −50,00 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −116 | 19 431 | −0,59 | 78,76 | −9 136 | 1 530 386 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 19 547 | 1,82 | ||||
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −399 | 19 197 | −2,04 | 78,76 | −31 425 | 1 511 956 | |
2019-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 19 596 | 5,52 | ||||
2019-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 67 | 18 571 | 0,36 | 60,99 | 4 086 | 1 132 645 | |
2018-10-01 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 57 | 18 504 | 0,31 | 75,26 | 4 290 | 1 392 611 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −12 000 | 12 800 | −48,39 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −1 560 | 1 560 | −50,00 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −4 000 | 18 447 | −17,82 | 79,73 | −318 920 | 1 470 779 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −9 133 | 22 447 | −28,92 | 80,40 | −734 293 | 1 804 739 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 12 000 | 31 580 | 61,29 | 51,30 | 615 600 | 1 620 054 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 106 | 19 580 | −5,35 | 80,40 | −88 922 | 1 574 232 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 560 | 20 686 | 8,16 | 44,90 | 70 044 | 928 801 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 221 | 19 126 | −6,00 | 80,40 | −98 168 | 1 537 730 | |
2018-08-06 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 20 347 | 10,90 | 32,93 | 65 860 | 670 027 | |
2018-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 62 | 18 347 | 0,34 | 69,54 | 4 311 | 1 275 850 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 650 | −50,00 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 0 | −100,00 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −221 | 18 285 | −1,19 | 69,03 | −15 256 | 1 262 214 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 18 506 | 3,64 | ||||
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −272 | 17 856 | −1,50 | 69,03 | −18 776 | 1 232 600 | |
2018-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 18 128 | 4,62 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 680 | 3 120 | −60,00 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 100 | |||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | 100 | 100 | |||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 328 | −0,57 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −100 | 17 328 | −0,57 | ||||
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 17 528 | −10,24 | 65,58 | −131 160 | 1 149 486 | |
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 717 | 19 528 | −15,99 | 65,25 | −242 534 | 1 274 202 | |
2018-04-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 680 | 23 245 | 25,21 | 44,90 | 210 132 | 1 043 700 | |
2018-04-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 184 | 18 565 | 1,00 | 60,16 | 11 069 | 1 116 870 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 27 000 | 27 000 | |||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 700 | −33,33 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 1 025 | −50,00 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −116 | 18 381 | −0,63 | 59,96 | −6 955 | 1 102 125 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 18 497 | 1,93 | ||||
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −352 | 18 147 | −1,90 | 59,96 | −21 106 | 1 088 094 | |
2018-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 18 499 | 5,87 | ||||
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 419 | 17 474 | −7,51 | 63,21 | −89 695 | 1 104 532 | |
2018-02-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 18 893 | 11,84 | 32,93 | 65 860 | 622 146 | |
2018-01-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 87 | 16 893 | 0,52 | 48,42 | 4 213 | 817 959 | |
2017-12-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −50 | 16 806 | −0,30 | ||||
2017-12-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −250 | 16 856 | −1,46 | ||||
2017-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 17 106 | 0,49 | 49,85 | 4 187 | 852 734 | |
2017-07-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 87 | 17 022 | 0,51 | 48,39 | 4 210 | 823 695 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 4 000 | −50,00 | ||||
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 068 | 16 935 | −15,34 | 52,26 | −160 334 | 885 023 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 20 003 | 25,00 | 32,93 | 131 720 | 658 699 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 369 | 16 003 | −7,88 | 52,26 | −71 544 | 836 317 | |
2017-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 17 372 | 13,01 | 26,09 | 52 180 | 453 235 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 1 300 | −33,33 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −241 | 15 372 | −1,54 | 51,90 | −12 508 | 797 807 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 15 613 | 4,34 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 14 963 | −1,94 | 51,90 | −15 362 | 776 580 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 14 963 | −1,94 | 51,90 | −15 362 | 776 580 | |
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 259 | 5,53 | ||||
2017-06-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 259 | 5,53 | ||||
2017-05-16 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −500 | 13 955 | −3,46 | 51,00 | −25 500 | 711 705 | |
2017-05-16 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 500 | 14 455 | −14,74 | 51,26 | −128 161 | 741 027 | |
2017-04-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 249 | 16 955 | 1,49 | 42,19 | 10 505 | 715 331 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 25 000 | 25 000 | |||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −350 | 1 050 | −25,00 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 2 050 | −33,33 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −148 | 16 706 | −0,88 | 41,93 | −6 206 | 700 483 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 350 | 16 854 | 2,12 | ||||
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −434 | 16 504 | −2,56 | 41,93 | −18 198 | 692 013 | |
2017-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 16 938 | 6,44 | ||||
2017-01-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 98 | 15 913 | 0,62 | 41,96 | 4 112 | 667 709 | |
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −475 | 15 815 | −2,92 | ||||
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −300 | 16 290 | −1,81 | 41,79 | −12 537 | 680 775 | |
2016-11-09 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 200 | 16 590 | −6,75 | 41,77 | −50 125 | 692 981 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 555 | 17 790 | −12,56 | 40,40 | −103 222 | 718 716 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 2 000 | −66,67 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −4 000 | 2 000 | −66,67 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 0 | −100,00 | ||||
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 158 | 20 345 | −13,44 | 39,18 | −123 730 | 797 117 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 23 503 | 20,51 | 26,09 | 104 360 | 613 193 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −3 257 | 19 503 | −14,31 | 39,18 | −127 609 | 764 128 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 4 000 | 22 760 | 21,32 | 27,63 | 110 520 | 628 859 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 360 | 18 760 | −6,76 | 39,18 | −53 285 | 735 017 | |
2016-11-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 20 120 | 11,04 | 19,26 | 38 520 | 387 511 | |
2016-10-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 116 | 18 120 | 0,64 | 38,06 | 4 415 | 689 647 | |
2016-07-01 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 91 | 18 004 | 0,51 | 45,34 | 4 126 | 816 301 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 1 950 | −25,00 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −241 | 17 913 | −1,33 | 41,06 | −9 895 | 735 508 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 18 154 | 3,71 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 17 504 | 4,79 | ||||
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −296 | 16 704 | −1,74 | 41,06 | −12 154 | 685 866 | |
2016-04-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 223 | 15 992 | 1,41 | 39,84 | 8 884 | 637 121 | |
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
A - Award | 27 100 | 27 100 | |||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 1 400 | 1 400 | |||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −1 025 | 3 075 | −25,00 | ||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −350 | 15 769 | −2,17 | ||||
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −434 | 16 119 | −2,62 | 39,87 | −17 304 | 642 665 | |
2016-03-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 1 025 | 16 553 | 6,60 | ||||
2016-01-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 96 | 15 528 | 0,62 | 41,85 | 4 018 | 649 847 | |
2015-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 89 | 15 432 | 0,58 | 45,35 | 4 036 | 699 841 | |
2015-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 72 | 15 343 | 0,47 | 55,36 | 3 986 | 849 335 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −650 | 2 600 | −20,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −235 | 15 271 | −1,52 | 55,70 | −13 090 | 850 595 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 650 | 15 506 | 4,38 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 14 856 | −1,91 | 55,70 | −16 097 | 827 479 | |
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 15 145 | 5,58 | ||||
2015-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 244 | 12 812 | 1,94 | 47,97 | 11 704 | 614 534 | |
2015-03-11 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −120 | 12 568 | −0,95 | 50,60 | −6 072 | 635 941 | |
2015-03-03 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 24 800 | 24 800 | |||||
2015-03-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 100 | 4 100 | |||||
2015-01-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 94 | 12 688 | 0,75 | 42,71 | 4 015 | 541 930 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 689 | 12 594 | −11,83 | 43,54 | −73 539 | 548 343 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 14 283 | 16,28 | 32,93 | 65 860 | 470 339 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 489 | 12 283 | −10,81 | 43,54 | −64 831 | 534 802 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 13 772 | 16,99 | 26,09 | 52 180 | 359 311 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 534 | 11 772 | −11,53 | 43,54 | −66 790 | 512 553 | |
2014-12-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 13 306 | 17,69 | 27,63 | 55 260 | 367 645 | |
2014-11-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −250 | 11 306 | −2,16 | ||||
2014-10-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 114 | 11 556 | 1,00 | 35,00 | 3 990 | 404 437 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 348 | 11 442 | −10,54 | 39,38 | −53 084 | 450 586 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 12 790 | 18,54 | 19,26 | 38 520 | 246 335 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 256 | 10 790 | −10,43 | 39,38 | −49 461 | 424 910 | |
2014-07-31 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 12 046 | 19,91 | 16,46 | 32 920 | 198 277 | |
2014-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 94 | 10 046 | 0,94 | 41,94 | 3 943 | 421 354 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 7 800 | 7 800 | |||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 3 250 | 3 250 | |||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 952 | −2,82 | 44,90 | −12 976 | 446 845 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 952 | −2,82 | 44,90 | −12 976 | 446 845 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 10 241 | 8,47 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 10 241 | 8,47 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 9 441 | −2,97 | 44,90 | −12 976 | 423 901 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 730 | 8,96 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 8 930 | −3,13 | 44,90 | −12 976 | 400 957 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 219 | 9,50 | ||||
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −289 | 8 419 | −3,32 | 44,90 | −12 976 | 378 013 | |
2014-06-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 8 708 | 10,12 | ||||
2014-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 276 | 7 397 | 3,88 | 41,28 | 11 393 | 305 330 | |
2014-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 58 | 7 121 | 0,82 | 40,38 | 2 342 | 287 510 | |
2013-11-22 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −85 | 7 063 | −1,19 | ||||
2013-10-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −390 | 7 148 | −5,17 | ||||
2013-10-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 72 | 7 538 | 0,96 | 32,26 | 2 323 | 243 191 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 793 | 7 466 | −19,36 | 33,03 | −59 223 | 246 602 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 259 | 27,55 | 27,63 | 55 260 | 255 826 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 757 | 7 259 | −19,49 | 33,03 | −58 034 | 239 765 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 016 | 28,51 | 26,69 | 53 380 | 240 637 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −9 401 | 7 016 | −57,26 | 33,03 | −310 515 | 231 738 | |
2013-08-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 10 000 | 16 417 | 155,84 | 29,92 | 299 200 | 491 197 | |
2013-07-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 77 | 6 417 | 1,21 | 29,68 | 2 285 | 190 444 | |
2013-06-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −600 | 6 340 | −8,65 | 32,43 | −19 458 | 205 606 | |
2013-06-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −1 400 | 6 940 | −16,79 | 32,41 | −45 374 | 224 925 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 4 000 | −33,33 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 728 | 8 340 | −17,16 | 33,20 | −57 370 | 276 888 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 10 068 | 24,79 | 26,09 | 52 180 | 262 674 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 787 | 8 068 | −18,13 | 33,20 | −59 328 | 267 858 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 855 | 25,46 | 27,63 | 55 260 | 272 294 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 466 | 7 855 | −15,73 | 33,20 | −48 671 | 260 786 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 9 321 | 27,32 | 19,26 | 38 520 | 179 522 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 358 | 7 321 | −15,65 | 33,20 | −45 086 | 243 057 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 8 679 | 29,94 | 16,46 | 32 920 | 142 856 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 800 | −50,00 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 6 679 | −4,16 | 32,93 | −9 550 | 219 939 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 6 679 | −4,16 | 32,93 | −9 550 | 219 939 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 969 | 12,97 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 6 459 | 14,14 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 5 659 | −4,87 | 32,93 | −9 550 | 186 351 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 949 | 15,54 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 5 149 | −5,33 | 32,93 | −9 550 | 169 557 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 5 439 | 17,25 | ||||
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 4 639 | −5,88 | 32,93 | −9 550 | 152 762 | |
2013-06-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 4 929 | 19,38 | ||||
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 4 129 | −32,63 | 33,41 | −66 820 | 137 951 | |
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −15 000 | 0 | −100,00 | ||||
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −15 000 | 6 129 | −70,99 | 34,00 | −510 008 | 208 389 | |
2013-05-30 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 15 000 | 21 129 | 244,74 | 31,40 | 471 000 | 663 451 | |
2013-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 234 | 6 129 | 3,97 | 32,36 | 7 572 | 198 316 | |
2013-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 000 | 5 895 | −25,33 | 30,89 | −61 781 | 182 099 | |
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −8 000 | 2 000 | −80,00 | ||||
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −7 328 | 7 895 | −48,14 | 30,74 | −225 263 | 242 692 | |
2013-02-20 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 8 000 | 15 223 | 110,76 | 26,69 | 213 520 | 406 302 | |
2013-01-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 85 | 7 223 | 1,19 | 26,55 | 2 257 | 191 789 | |
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −10 000 | 7 138 | −58,35 | 28,03 | −280 301 | 200 079 | |
2012-12-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 10 000 | 17 138 | 140,10 | 25,03 | 250 300 | 428 964 | |
2012-12-07 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −288 | 7 138 | −3,88 | ||||
2012-10-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 7 426 | 1,14 | 27,08 | 2 274 | 201 059 | |
2012-07-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 84 | 7 342 | 1,16 | 26,29 | 2 208 | 192 995 | |
2012-06-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 000 | 7 258 | −29,25 | 27,00 | −81 000 | 195 966 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 6 000 | −25,00 | ||||
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 640 | 10 258 | −13,78 | 26,85 | −44 034 | 275 427 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 11 898 | 20,21 | 19,26 | 38 520 | 229 155 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 508 | 9 898 | −13,22 | 26,85 | −40 490 | 265 761 | |
2012-06-08 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 11 406 | 21,26 | 16,46 | 32 920 | 187 743 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
A - Award | 10 000 | 10 000 | |||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
A - Award | 4 000 | 4 000 | |||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 3 200 | −20,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 2 400 | −25,00 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 1 600 | −33,33 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 9 406 | −2,99 | 26,09 | −7 566 | 245 403 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 696 | 8,99 | ||||
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 8 896 | −3,16 | 26,09 | −7 566 | 232 097 | |
2012-06-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 9 186 | 9,54 | ||||
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Rsus (restricted Stock Units) |
M - Exercise | −800 | 0 | −100,00 | ||||
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −290 | 7 366 | −3,79 | 27,24 | −7 900 | 200 650 | |
2012-05-18 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 800 | 7 656 | 11,67 | ||||
2012-04-03 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 289 | 6 856 | 4,40 | 28,38 | 8 201 | 194 549 | |
2012-03-19 |
|
4 | CNMD |
CONMED CORP
Common Stock |
G - Gift | −51 | 6 567 | −0,77 | 29,74 | −1 517 | 195 303 | |
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −2 906 | 0 | −100,00 | ||||
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −2 906 | 6 618 | −30,51 | 29,45 | −85 582 | 194 900 | |
2012-03-15 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 906 | 9 524 | 43,91 | 25,89 | 75 236 | 246 576 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 256 | 2 906 | −52,84 | ||||
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 256 | 6 618 | −32,98 | 29,94 | −97 481 | 198 136 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 256 | 9 874 | 49,20 | 25,89 | 84 298 | 255 638 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Options To Purchase Common Stock |
M - Exercise | −3 838 | 6 162 | −38,38 | ||||
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
S - Sale | −3 838 | 6 618 | −36,71 | 29,50 | −113 221 | 195 231 | |
2012-03-12 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 3 838 | 10 456 | 57,99 | 25,89 | 99 366 | 270 706 | |
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Sars (Stock Appreciation Rights) |
M - Exercise | −2 000 | 8 000 | −20,00 | ||||
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
F - Taxes | −1 571 | 6 618 | −19,18 | 29,04 | −45 622 | 192 187 | |
2012-03-05 |
|
4 | CNMD |
CONMED CORP
Common Stock |
M - Exercise | 2 000 | 8 189 | 32,32 | 19,26 | 38 520 | 157 720 | |
2012-01-04 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 86 | 6 189 | 1,41 | 24,39 | 2 097 | 150 928 | |
2008-04-02 |
|
4 | CNMD |
CONMED CORP
Common Stock |
A - Award | 256 | 1 689 | 17,86 | 24,36 | 6 236 | 41 144 |